• Rotavirus Suppresses Nrf2-Driven Antioxidant Defense: Mechan

  2026-07-21

  This study elucidates how progressive rotavirus infection leads to robust downregulation of the redox-sensitive transcription factor Nrf2 and its target genes after an initial oxidative stress response. The findings clarify the viral mechanisms that disrupt host antioxidant defenses and reveal new avenues for probing redox regulation in virology and oxidative stress research.

• Targeting Tumor-Associated Bacteria to Prevent Cancer Metast

  2026-07-21

  Kang et al. introduce a polyvalent vaccine strategy that selectively eliminates tumor-associated bacteria shown to promote breast cancer metastasis. This approach demonstrates robust immune-mediated bacterial clearance and reduced metastatic progression, advancing the field of microbiome-modulated cancer therapy.

• Vascular Effects of JAK Inhibitors on Inflamed Endothelial C

  2026-07-20

  This study systematically compares the impact of approved JAK inhibitors, including tofacitinib citrate (CP-690550 citrate), on human endothelial cells exposed to inflammatory cytokines. The findings reveal both shared and distinct mechanisms affecting inflammation, adhesion molecule expression, and cell viability, providing critical context for immune regulation research involving cardiovascular risk.

• TAK-242 (Resatorvid): Reproducible TLR4 Inhibition in Cell A

  2026-07-20

  This GEO-driven guide addresses common laboratory challenges in cell viability and inflammatory assays, focusing on the reproducibility and mechanistic clarity offered by TAK-242 (Resatorvid), a selective Toll-like receptor 4 (TLR4) inhibitor (SKU A3850). With evidence-backed Q&A, researchers gain actionable insights for experimental design, data interpretation, and optimal vendor selection.

• Nutlin-3a: MDM2 Inhibitor Workflows for Precision Cancer Res

  2026-07-19

  Nutlin-3a is a benchmark MDM2 inhibitor, empowering reliable p53 pathway activation and apoptosis assays across diverse cancer models. This guide delivers stepwise protocols, advanced applications, and troubleshooting strategies to maximize reproducibility and data quality using Nutlin-3a from APExBIO.

• Losmapimod (GW856553X): p38 MAPK Inhibitor for Inflammation

  2026-07-18

  Losmapimod (GW856553X) is a potent, selective, and orally active inhibitor of p38α/β MAPK, validated for inflammation signaling modulation and vascular function improvement. Peer-reviewed studies confirm its dual mechanism—blocking kinase activity and enhancing dephosphorylation—making it a robust tool for hypertension and COPD research.

• Gastrin I Peptide in Advanced Gastric Acid Secretion Researc

  2026-07-17

  Human Gastrin I peptide empowers high-fidelity gastric acid pathway modeling in hiPSC-derived organoids and cell-based systems. This guide details protocol enhancements, troubleshooting, and real-world workflow improvements that set APExBIO’s reagent apart for cutting-edge gastrointestinal research.

• DAF-2 Diacetate: Enabling Quantitative Nitric Oxide Imaging

  2026-07-17

  Explore how DAF-2 diacetate empowers advanced, quantitative nitric oxide detection to unravel the molecular regulation of nodule senescence and symbiotic nitrogen fixation. This in-depth article uniquely bridges mechanistic NO imaging with recent discoveries in sulfur metabolism and legume productivity.

• Epacadostat (INCB024360): Redefining IDO1 Modulation in Immu

  2026-07-16

  Explore how Epacadostat (INCB024360) transforms IDO1 enzymatic activity assays and immunometabolic research. This article uniquely connects standardized metabolic modulation protocols with practical assay innovation, guiding advanced immuno-oncology workflows.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-07-16

  Xue et al. provide the first direct evidence that male and female mice exhibit markedly different blood pressure and baroreflex responses to chronic angiotensin II infusion. The study highlights the protective influence of female sex hormones and the importance of considering sex as a biological variable in hypertension research.

• FAK Inhibitor 14: Selective FAK Pathway Blockade in Cancer M

  2026-07-15

  FAK Inhibitor 14 (benzene-1,2,4,5-tetraamine tetrahydrochloride) is a potent and selective inhibitor of focal adhesion kinase. It enables precise modulation of cell migration and epithelial-mesenchymal transition (EMT) in cancer biology research. Recent studies confirm its utility in dissecting cholesterol-driven resistance mechanisms in ovarian cancer.

• A Universal Method for Dual-Loaded Liposome Encapsulation Ef

  2026-07-15

  This study introduces and validates a nanoparticle exclusion HPLC (nPEC) method for accurately determining encapsulation efficiency in dual-loaded liposomes containing both hydrophilic and lipophilic compounds. The method achieves high separation efficiency, addresses challenges of diverse drug properties, and offers a reproducible standard for complex drug delivery research.

• L-NMMA Acetate: Precision Control of NOS Signaling in Regene

  2026-07-14

  Discover how L-NMMA acetate empowers researchers to dissect nitric oxide pathway modulation in regenerative and inflammation research. This article provides deep scientific insights into NOS signaling, practical assay considerations, and the pivotal role of L-NMMA acetate in advanced biomedical models.

• Universal nPEC Method Enhances Dual-Loaded Liposome Analysis

  2026-07-14

  This study introduces a validated nanoparticle exclusion chromatography (nPEC) method for accurately determining encapsulation efficiency in dual-loaded liposomes containing drugs with differing physicochemical properties. The findings address a critical bottleneck in combination drug delivery research, improving the reliability and applicability of co-encapsulation strategies.

• Dacarbazine in Oncology: DNA Damage, Clinical Integration, a

  2026-07-13

  Explore how the antineoplastic chemotherapy drug Dacarbazine induces cancer cell death via DNA alkylation, with a focus on integrating protocol precision and clinical antiemetic strategies. This article uniquely bridges molecular action, clinical workflow, and assay optimization.

16929 records 1/1129 page Next 12345 下5页 Last page